A fast and easy way to find out about all new FDA approved cancer treatments.
Monday, February 4, 2013
Pazopanib approved for soft tissue sarcoma
Votrient (pazopanib), an oral tyrosine kinase inhibitor, has been approved for the treatment of advanced soft tissue sarcoma in patients who have received prior chemotherapy.
No comments:
Post a Comment